Clinical trial
Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis
NCT06522035 is registered in ClinicalTrials.gov with Enlivex Therapeutics Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis
- Lead sponsor
- Enlivex Therapeutics Ltd.
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- August 1, 2024
- Completion date
- April 8, 2026
- Enrollment
- 5 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.